CERA is led by a multi-disciplinary team with advanced expertise in genomics, bioethics, legal analysis, social science research, and related fields. The CERA leadership identifies priority areas in ELSI, ensures the integrity of our collection of ELSI resources and analysis, and guides the community building and engagement activities of the Center.

Advisory Board

The Advisory Board provides ideas and insights to guide CERA research projects and advises on emerging trends in ELSI of genetics and genomics research. In addition, the membership identifies new topics for commissions, collections and special issues, peer-reviews original CERA content, and writes occasional editorials.  

Altovise Ewing

Altovise Ewing

Altovise T. Ewing, Ph.D., LCGC

Altovise T. Ewing, Ph.D., LCGC is a Health Equity Geneticist and Certified Genetic Counselor. Dr. Ewing’s work focuses on the ethical, legal and social implications of genetic and genomic advancements in medicine and public health, equitable implementation of personalized medicine, and research ethics involving inclusion of diverse populations in genetics, genomics and biobanking research.

Aaron Panofsky, Ph.D. CERA Advisory Board

Aaron Panofsky, Ph.D.

Aaron Panofsky, Ph.D. is Professor in the Institute for Society and Genetics, Public Policy, and Sociology and also Director of the Institute for Society and Genetics at the University of California, Los Angeles. Dr. Panofsky’s research focuses on the history, intellectual organization, and social and political dimensions of genetics.

Barbara J. Evans, CERA Advisory Board

Barbara J. Evans, J.D., LL.M., Ph.D.

Barbara J. Evans, J.D., LL.M., Ph.D. is a Professor of Law and Stephen C. O’Connell Chair at the University of Florida Levin College of Law and Professor of Engineering at the University of Florida Wertheim College of Engineering. Dr. Evans’ work focuses on data privacy and the regulation of machine-learning medical software, genomic technologies, and diagnostic testing.

Kurt Christensen, PhD Advisory Board

Kurt Christensen, PhD

Kurt Christensen, PhD, is an Assistant Professor of Population Medicine at the Harvard Pilgrim Health Care Institute and Harvard Medical School. His research addresses the medical, behavioral, and economic impact of integrating genomic testing into the care of healthy individuals using data from clinical trials and simulation modeling. He currently leads a collaboration with Sanford Health to examine its population genetic screening program, and contributes to numerous other NIH-funded studies.

Kyle Brothers, M.D., Ph.D. Advisory Board

Kyle Brothers, M.D., Ph.D.

Kyle Brothers, M.D., Ph.D. serves as Chief Scientific Officer for Norton Children's Research Institute in Louisville, Kentucky and holds the Endowed Chair for Pediatric Clinical and Translational Research at the University of Louisville. Dr. Brothers is a pediatrician and bioethicist who conducts research on ethical issues in the translation of genomic technologies. He is a practicing primary care pediatrician and serves as a clinical ethics consultant at Norton Children's Hospital.

Genevieve Wojcik, Ph.D. Advisory Board

Genevieve Wojcik, Ph.D.

Genevieve Wojcik, Ph.D. is an Assistant Professor of Epidemiology at the Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland. As a statistical geneticist and genetic epidemiologist, Dr. Wojcik’s research focuses on method development for diverse populations, specifically in admixed populations, to help address existing health inequities. Her work also focuses on the genetic susceptibility to infectious disease and vaccine response.